Craft

Actuate Therapeutics

Total Funding

$31.2 M

Actuate Therapeutics Summary

Company Summary

Overview
Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic agents for patients with cancer or inflammatory diseases. It has developed 9-ING-41 agent, which shows significant anti-tumor activity in many models of difficult-to-treat cancers, including cancers of the brain, pancreas, lung, breast, and lymphomas.
Type
Private
Status
Active
Founded
2015
HQ
Fort Worth, TX, US | view all locations
Website
https://actuatetherapeutics.com/
Cybersecurity rating
Sectors

Key People

  • Richard Kenley

    Richard Kenley, Vice President, Chemistry, Manufacturing, & Controls

    • Aaron G.L. Fletcher
    • Les Kreis, Director

      LocationsView all

      2 locations detected

      • Fort Worth, TX HQ

        United States

        1751 River Run #400

      • Dublin, D

        Ireland

      Footer menu